Review
Copyright ©The Author(s) 2020.
World J Transplant. Jan 18, 2020; 10(1): 1-14
Published online Jan 18, 2020. doi: 10.5500/wjt.v10.i1.1
Table 2 Other major therapeutic additives in models of ex vivo liver machine perfusion
Ref.Ex vivoperfusion typeTherapeuticProblemAnimalModelSamplesizeEx vivo perfusiontime (h)Outcomes                                                            
Goldaracena et al[9], 2016SNMPAnti-inflammatory agentsIRIPigTransplantation54During EVLP: lower AST, TNF-α, IL-6
Lower HA levels, β-galactosidase and higher IL-10 (nonsignificant)
After transplantation: Lower bilirubin, lower IL-6, lower cleaved caspase 3 staining, intact sinusoidal endothelial cell lining
(Alprostadil, n-acetylcysteine, carbon monoxide, sevoflurane)
Lower AST, TNF-α, HA,
ALP and higher IL-10 (nonsignificant)
Rigo et al[65], 2018NMPHLSC-EVIRIRatEVLP94HLSC-EV uptake in treated livers
Reduced necrosis and apoptosis on histology, lower Suzuki tissue injury score, lower apoptosis, lower AST and LDH, lower HIF-1α & TGF-β1 (hypoxia induced markers)
NMP had low hematocrit to induce hypoxia
Beal et al[66], 2019NMPEnkephalinIRIRatEVLP6410 μmol/L determined to be optimal concentration in an in vitro model: Lower ALT and MDA; better preservation of structural architecture; decreased caspase-3 expression;
(δ-opioid agonist)
decreased TUNEL staining; decreased phosphorylation of p38 and JNK; increased expression of p-Akt, PI3K, p-Bad and Bcl-2
Yu et al[67], 2019HMPNLRP3 InflammasomeIRIPigTransplantation62All reduced in HMP-postop group with added mcc950 in perfusate and IV administration of mcc950
After transplantation: TNF-α, IL-1β, β-galactosidase, post-reperfusion serum ALT and AST, MDA, apoptosis staining, caspase-1 levels
Inhibitor mcc950